Life Length Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
65
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.25M
- Investors
-
2
Life Length General Information
Description
Operator of a biotechnology company intended to deliver services in telomere and telomerase measurement and diagnostics. The company develops proprietary technology for telomere analysis through the determination of multiple telomere-associated variables, enabling the pharmaceutical industry, clinics, and hospitals, as well as research laboratories to bring analysis into their studies and research projects.
Contact Information
Website
lifelength.comCorporate Office
- Calle Miguel Angel, 11
- 2nd floor
- 28010 Madrid
- Spain
Corporate Office
- Calle Miguel Angel, 11
- 2nd floor
- 28010 Madrid
- Spain
Life Length Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 10-Oct-2023 | $4.25M | Completed | Generating Revenue | ||
| 6. Equity Crowdfunding | 09-Aug-2019 | Completed | Generating Revenue | |||
| 5. Seed Round | 01-Apr-2019 | Completed | Generating Revenue | |||
| 4. Seed Round | 03-Apr-2017 | Completed | Generating Revenue | |||
| 3. Grant | 29-Sep-2016 | Completed | Generating Revenue | |||
| 2. Debt - General | 16-Nov-2012 | $386K | $9.6M | Completed | Generating Revenue | |
| 1. Early Stage VC | 11-Nov-2012 | $9.2M | $9.2M | Completed | Generating Revenue |
Life Length Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Life Length Comparisons
Industry
Financing
Details
Life Length Competitors (8)
One of Life Length’s 8 competitors is Datar Cancer Genetics, a Venture Capital-Backed company based in Nashik, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Datar Cancer Genetics | Venture Capital-Backed | Nashik, India | ||||
| Promethease | Corporate Backed or Acquired | |||||
| Ambry Genetics | Private Equity-Backed | Aliso Viejo, CA | ||||
| Dante Labs | Venture Capital-Backed | New York, NY | ||||
| Strand (Biotechnology) | Formerly VC-backed | Bangalore, India |
Life Length Patents
Life Length Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220106635-A1 | Method for measuring telomere associated variables and uses thereof for the diagnosis and/or prognosis of telomeric-associated diseases | Pending | 26-Dec-2018 | ||
| EP-3674418-A1 | Method for measuring telomere associated variables and uses thereof for the diagnosis and/or prognosis of telomeric-associated diseases | Inactive | 26-Dec-2018 | ||
| EP-3902925-C0 | Method for measuring telomere associated variables and uses thereof for the diagnosis and/or prognosis of telomeric-associated diseases | Active | 26-Dec-2018 | ||
| EP-3902925-B1 | Method for measuring telomere associated variables and uses thereof for the diagnosis and/or prognosis of telomeric-associated diseases | Active | 26-Dec-2018 | ||
| EP-3902925-A1 | Method for measuring telomere associated variables and uses thereof for the diagnosis and/or prognosis of telomeric-associated diseases | Active | 26-Dec-2018 | C12Q1/6851 |
Life Length Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Life Length Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Horizon 2020 SME Instrument | Government | |||
| ZMAY Holdings | Corporation | Minority |
Life Length FAQs
-
When was Life Length founded?
Life Length was founded in 2010.
-
Where is Life Length headquartered?
Life Length is headquartered in Madrid, Spain.
-
What is the size of Life Length?
Life Length has 65 total employees.
-
What industry is Life Length in?
Life Length’s primary industry is Biotechnology.
-
Is Life Length a private or public company?
Life Length is a Private company.
-
What is Life Length’s current revenue?
The current revenue for Life Length is .
-
How much funding has Life Length raised over time?
Life Length has raised $22.6M.
-
Who are Life Length’s investors?
Horizon 2020 SME Instrument and ZMAY Holdings have invested in Life Length.
-
Who are Life Length’s competitors?
Datar Cancer Genetics, Promethease, Ambry Genetics, Dante Labs, and Strand (Biotechnology) are some of the 8 competitors of Life Length.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
